PDB Short entry for 2A4X HEADER ANTIMICROBIAL PROTEIN 30-JUN-05 2A4X TITLE CRYSTAL STRUCTURE OF MITOMYCIN C-BINDING PROTEIN COMPLEXED WITH METAL- TITLE 2 FREE BLEOMYCIN A2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOMYCIN-BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CAESPITOSUS; SOURCE 3 ORGANISM_TAXID: 53502; SOURCE 4 GENE: MRD; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-MRD KEYWDS ALFA/BETA PROTEIN, MITOMYCIN C-BINDING PROTEIN, BLEOMYCIN A2, KEYWDS 2 ANTIMICROBIAL PROTEIN, STRUCTURAL GENOMICS EXPDTA X-RAY DIFFRACTION AUTHOR N.DANSHIITSOODOL,C.A.DE PINHO,Y.MATOBA,T.KUMAGAI,M.SUGIYAMA REVDAT 4 13-MAR-24 2A4X 1 REMARK REVDAT 3 12-MAY-09 2A4X 1 REMARK DBREF REVDAT 2 24-FEB-09 2A4X 1 VERSN REVDAT 1 18-JUL-06 2A4X 0 JRNL AUTH N.DANSHIITSOODOL,C.A.DE PINHO,Y.MATOBA,T.KUMAGAI,M.SUGIYAMA JRNL TITL THE MITOMYCIN C (MMC)-BINDING PROTEIN FROM MMC-PRODUCING JRNL TITL 2 MICROORGANISMS PROTECTS FROM THE LETHAL EFFECT OF BLEOMYCIN: JRNL TITL 3 CRYSTALLOGRAPHIC ANALYSIS TO ELUCIDATE THE BINDING MODE OF JRNL TITL 4 THE ANTIBIOTIC TO THE PROTEIN JRNL REF J.MOL.BIOL. V. 360 398 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16756991 JRNL DOI 10.1016/J.JMB.2006.05.017 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.1 REMARK 3 NUMBER OF REFLECTIONS : 47057 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2348 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5686 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 306 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2030 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 293 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.760 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.200 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.460 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : BLEO-5.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO.TOP REMARK 3 TOPOLOGY FILE 2 : TOPH19.PEP.TOP REMARK 3 TOPOLOGY FILE 3 : BM2.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A4X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1000033492. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL38B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52971 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.370 REMARK 200 RESOLUTION RANGE LOW (A) : 200.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : 16.00 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 52.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, MES, PH 6.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.62400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.93100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.20250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.93100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.62400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 26.20250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 HIS A 133 REMARK 465 HIS A 134 REMARK 465 HIS A 135 REMARK 465 HIS A 136 REMARK 465 HIS A 137 REMARK 465 HIS A 138 REMARK 465 MET B 201 REMARK 465 PRO B 330 REMARK 465 LEU B 331 REMARK 465 GLU B 332 REMARK 465 HIS B 333 REMARK 465 HIS B 334 REMARK 465 HIS B 335 REMARK 465 HIS B 336 REMARK 465 HIS B 337 REMARK 465 HIS B 338 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 7 CA - CB - CG ANGL. DEV. = 16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 261 70.45 -171.81 REMARK 500 TRP B 264 127.57 -27.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BLM A 700 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLM A 700 REMARK 999 REMARK 999 SEQUENCE REMARK 999 A SEQUENCE DATABASE REFERENCE FOR THIS PROTEIN REMARK 999 WHICH DERIVES FROM STREPTOMYCES CAESPITOSUS REMARK 999 DOES NOT CURRENTLY EXIST. REMARK 999 THE 8 C-TERMINAL RESIDUES WERE HIS TAGS. DBREF 2A4X A 1 138 PDB 2A4X 2A4X 1 138 DBREF 2A4X B 201 338 PDB 2A4X 2A4X 201 338 SEQRES 1 A 138 MET SER ALA ARG ILE SER LEU PHE ALA VAL VAL VAL GLU SEQRES 2 A 138 ASP MET ALA LYS SER LEU GLU PHE TYR ARG LYS LEU GLY SEQRES 3 A 138 VAL GLU ILE PRO ALA GLU ALA ASP SER ALA PRO HIS THR SEQRES 4 A 138 GLU ALA VAL LEU ASP GLY GLY ILE ARG LEU ALA TRP ASP SEQRES 5 A 138 THR VAL GLU THR VAL ARG SER TYR ASP PRO GLU TRP GLN SEQRES 6 A 138 ALA PRO THR GLY GLY HIS ARG PHE ALA ILE ALA PHE GLU SEQRES 7 A 138 PHE PRO ASP THR ALA SER VAL ASP LYS LYS TYR ALA GLU SEQRES 8 A 138 LEU VAL ASP ALA GLY TYR GLU GLY HIS LEU LYS PRO TRP SEQRES 9 A 138 ASN ALA VAL TRP GLY GLN ARG TYR ALA ILE VAL LYS ASP SEQRES 10 A 138 PRO ASP GLY ASN VAL VAL ASP LEU PHE ALA PRO LEU PRO SEQRES 11 A 138 LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 138 MET SER ALA ARG ILE SER LEU PHE ALA VAL VAL VAL GLU SEQRES 2 B 138 ASP MET ALA LYS SER LEU GLU PHE TYR ARG LYS LEU GLY SEQRES 3 B 138 VAL GLU ILE PRO ALA GLU ALA ASP SER ALA PRO HIS THR SEQRES 4 B 138 GLU ALA VAL LEU ASP GLY GLY ILE ARG LEU ALA TRP ASP SEQRES 5 B 138 THR VAL GLU THR VAL ARG SER TYR ASP PRO GLU TRP GLN SEQRES 6 B 138 ALA PRO THR GLY GLY HIS ARG PHE ALA ILE ALA PHE GLU SEQRES 7 B 138 PHE PRO ASP THR ALA SER VAL ASP LYS LYS TYR ALA GLU SEQRES 8 B 138 LEU VAL ASP ALA GLY TYR GLU GLY HIS LEU LYS PRO TRP SEQRES 9 B 138 ASN ALA VAL TRP GLY GLN ARG TYR ALA ILE VAL LYS ASP SEQRES 10 B 138 PRO ASP GLY ASN VAL VAL ASP LEU PHE ALA PRO LEU PRO SEQRES 11 B 138 LEU GLU HIS HIS HIS HIS HIS HIS HET BLM A 700 29 HETNAM BLM BLEOMYCIN A2 HETSYN BLM N1-[3-(DIMETHYLSULFONIO)-PROPYL]BLEOMYCINAMIDE FORMUL 3 BLM C55 H85 N17 O21 S3 FORMUL 4 HOH *293(H2 O) HELIX 1 1 ASP A 14 LYS A 24 1 11 HELIX 2 2 PRO A 30 ALA A 36 5 7 HELIX 3 3 VAL A 54 ASP A 61 1 8 HELIX 4 4 ASP A 81 ALA A 95 1 15 HELIX 5 5 ASP B 214 LYS B 224 1 11 HELIX 6 6 PRO B 230 ALA B 236 5 7 HELIX 7 7 ASP B 244 GLY B 246 5 3 HELIX 8 8 VAL B 254 TYR B 260 1 7 HELIX 9 9 ASP B 281 ALA B 295 1 15 SHEET 1 A 7 HIS A 38 VAL A 42 0 SHEET 2 A 7 ARG A 48 THR A 53 -1 O TRP A 51 N THR A 39 SHEET 3 A 7 ARG A 4 VAL A 12 1 N PHE A 8 O ALA A 50 SHEET 4 A 7 PHE B 273 GLU B 278 -1 O ALA B 276 N LEU A 7 SHEET 5 A 7 VAL B 322 PRO B 328 1 O ASP B 324 N PHE B 277 SHEET 6 A 7 GLN B 310 LYS B 316 -1 N ALA B 313 O LEU B 325 SHEET 7 A 7 GLU B 298 ALA B 306 -1 N TRP B 304 O TYR B 312 SHEET 1 B 7 GLY A 99 ALA A 106 0 SHEET 2 B 7 GLN A 110 LYS A 116 -1 O TYR A 112 N TRP A 104 SHEET 3 B 7 VAL A 122 PRO A 128 -1 O LEU A 125 N ALA A 113 SHEET 4 B 7 PHE A 73 GLU A 78 1 N PHE A 77 O ASP A 124 SHEET 5 B 7 ARG B 204 VAL B 212 -1 O ARG B 204 N GLU A 78 SHEET 6 B 7 ARG B 248 THR B 253 1 O ALA B 250 N PHE B 208 SHEET 7 B 7 HIS B 238 VAL B 242 -1 N THR B 239 O TRP B 251 SITE 1 AC1 10 GLU A 78 TRP A 108 GLN A 110 TYR A 112 SITE 2 AC1 10 VAL A 122 ASP A 124 PHE A 126 HOH A 532 SITE 3 AC1 10 GLU B 240 ARG B 248 CRYST1 47.248 52.405 107.862 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021165 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019082 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009271 0.00000